Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 32
Healthy volunteers: yes

Brief summary:
The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distributed by Teva Pharmaceuticals USA) and Flomax® (tamsulosin hydrochloride)0.4 mg capsules (Manufactured by Yamanouchi Pharmaceutical Co., Japan; distributed by Boehringer Ingelheim Pharmaceutical Inc. USA), after a single-dose in healthy subjects under fed conditions.

Detailed description:

Arms:
arm 1: 0.4 mg Capsule arm 2: 0.4 mg Capsule

Interventions: intervention 1: Tamsulosin intervention 2: Tamsulosin
Intervention descriptions: intervention 1: Test 0.4 mg Capsule intervention 2: Reference Listed 0.4 Capsule

Protocol document: